CLINICAL RESEARCH

 

Our Associate, Dr. Patrick Yeramian, has over 20 years of experience with the clinical development of innovative formulations, new chemical entities and biotechnology derived drugs including integrated development plans and Phase I-IV clinical trials.  Since 2000, Dr. Yeramian has provided support and guidance to emergent companies in the US and Europe to develop their global registration strategy and implement their US and international clinical plans.  

 

Please call us at (954) 655-8746 or e-mail us at info@acehartley.com. We will promptly respond.